Macrophage Expression of Interleukin-1 in Lymphoepithelioid Cell (“Lennert's”) Lymphoma

Leukemia and Lymphoma

Volumn 21, Issue 42067, 1996, Pages 305-309

  Diaz, Jose I ^a   Muro Cacho, Carlos A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Lennert's lymphoma; lymphoepithelioid lymphoma; Macrophage Interleukin 1

Indexed keywords

INTERLEUKIN 1;

APOPTOSIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOEPITHELIOMA; MACROPHAGE; NONHODGKIN LYMPHOMA; PHAGOCYTE; PRIORITY JOURNAL; T CELL LYMPHOMA; TUMOR CELL;

HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERLEUKIN-1; LYMPHOMA, T-CELL; MACROPHAGE ACTIVATION; MACROPHAGES; MICROSCOPY, ELECTRON;

EID: 0029936432     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199209067611     Document Type: Article

References (31)

1. Takeshita M. Cytokine (interleukin-I alpha, interleukin-beta, tumor necrosis factor alpha and interleukin-6)–possessing cells in lymph nodes of malignant lymphoma. Pathol. Res. Pract 1993; 189 (1) 18 – 25
2. Muller H. Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma. Verhandlungen der Deuschen Gesellschaft fur Pathologie 1992; 76: 164 – 168
3. Hornung R. L., Kiertscher S. M., Mathews H. L. Systemic IL-1 and adjuvant treatment of an experimental tumnor. I. Immune status following tumor rechallenge. Biotherapy 1992; 5 (3) 227 – 237
4. Johnson C. S. Modulation of chemotherapy antineoplastic agents with biologic agents: enhancement of antitumor activities by interleukin-1. Current Opinion in Oncology 1992; 4 (6) 1108 – 1115
5. Katsanis E. Infusions of interleukin-I alpha after autologous transplantation for Hodgkin's disease and non-Hodgkin's lymphoma induce effector cells with antilymphoma cytolytic activity. J. Clin. Immunol 1994; 14 (3) 205 – 211
6. Mantovani A. Origin and regulation of tumor-associated macrophages: the role of tumor-derived chemotactic factor. Biochem. Biophys. Acta 1986; 865: 5967
7. Platanias L. C., Vogelzang N. J. Interleukin-1: Biology, Pathophysiology, and Clinical Prospects. Am. J. Med 1990; 89: 621 – 629
8. Bonta I. L., Ben-Efraim S. Involvement of inflammatory mediators in macrophage antitumor activity. J. Leukocyte Biology 1993; 54 (6) 613 – 626
9. Dinarello C. A. Interleukin-I and Interleukin-1 antagonism. Blood 1991; 77 (8) 1627 – 1652
10. Johnson C. S. Interleukin-1: therapeutic potential for solid tumors. Cancer Investigation 1993; 11 (5) 600 – 8
11. Lennert K., Mestdagh J. Lymphogranulomatosen mit Konstant hohem epithelioid zell gehalt. Virchows Arch. [Pathol. Anat.] 1968; 344: 120
12. Palutke M., Varadachari C., Weise R. Lennert's Lymphoma: AT cell Neoplasm. Am. J. Clin. Pathol 1978; 69: 643 – 645
13. Hsu S. M. The use avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabeled antibody PAP procedures. J. Histochem. Cytochem 1981; 29: 577 – 580
14. Sheibani K., Tubbs R. Enzyme immunohistochemistry: Technical aspects. Sem. Diag. Pathol 1984; 1: 235 – 250
15. Muller H. Human mammary carcinoma. A model for the relationship between tumor proliferation, tumor-associated macrophages and prognostic factors. Veroffentlichungen aus der pathologie 1992; 138: 1 – 235
16. McBride W. H. Phenotype and functions of intratumor macrophages. Biochem. Biophys. Acta 1986; 823: 227 – 245
17. Hibbs J. B. Dissemination between neoplastic and non-neoplastic cells in vitro by activated macrophages. J. Natl. cancer Inst 1978; 53: 1487 – 1492
18. Nelson D. S. Macrophages as effectors of cell-mediated immunity. Macrophages and Cellular Immunity, AI Laskin, H LeChevalier. CRC Press, Cleveland, OHUSA
19. Boteach D., Gallily R. Killing of virus-induced thymic lymphoma cells obtained from primary and early transfers by activated macrophages. Israel J. of Medical Sciences 1988; 24 (9–10) 518 – 521
20. Bartholeyns J. Immune control of neoplasia by macrophages: from mechanism to clinical application. Anticancer Research 1992; 12 (6A) 1867
21. Maas R. A. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages. Immunobiology 1992; 186 (3–4) 214 – 229
22. Ryoyama K. Effector molecules from antitumor macrophages induced with OK-432 and cyclophosphamide. Cancer Immunology, Immunotherapy 1992; 35 (1) 7 – 13
23. Charak B. S., Agah R., Mazumder A. Granulocyte-macrophage colony-stimulating factor-induced antibody-dependent cellular cytotoxicity in bone marrow macrophages: application in bone marrow transplantation. Blood 1993; 8112: 3474 – 3479
24. Singh S. M., Sodhi A. Interaction between cisplatin-treated macrophages and Dalton's lymphoma cells in vitro. Exp. Cell. Biol 1988; 56 (102) 1 – 11
25. Godambe S. A., Chaplin D. D., Bellone C. J. Regulation of IL-1 gene expression: differentil responsiveness of murine macrophage lines. Cytokine 1993; 5 (4) 327 – 335
26. Reichel H., Koeffler H. P., Norman A. W. Production of 1-alpha, 25-dihydroxyvitamin D3 by hematopoietic cells. Prog. Clin. Biol. Res 1990; 332: 81 – 97
27. Ruggiero V., Baglioni C. Synergistic anti-proliferative activity of interlukin-I and tumor necrosis factor. J. Immunol 1987; 138: 661 – 663
28. Rogers H. W., Tripp C. S., Schreiber Rd., Unanue E. R. Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine listeriosis. J. Immunol 1994; 153 (5) 2093 – 2101
29. Suzuki K. Differential production of interleukin 1 (IL-1), IL6, tumor necrosis factor, and IL-1 eceptor antagonist by humna monocytes stimulated with Mycobacterium Leprae and M Bovis BCG. Int. J. Leprosy and other Mycobacterial Diseases 1993; 61 (4) 609 – 618
30. Shimizu S. An established CD4+ T lymphoma cell line derived from a patient with so-called Lennert's Lymphoma: possible roles of cytokines in histopathogenesis. Blood 1988; 71 (1) 196 – 203
31. Klein M. A., Jaffe R., Neiman R. S. Lennert's Lymphoma with transformation to malignant lymphoma histiocytic type (immunoblastic sarcoma). Am. J. Clin. Pathol 1977; 68: 601 – 605